Navigation Links
Sofie Biosciences Is Awarded a US Patent on a Family of Novel PET Probes for Use in Oncology and Immunology
Date:1/24/2012

CULVER CITY, Calif., Jan. 24, 2012 /PRNewswire/ -- Sofie Biosciences, Inc., offering a comprehensive range of products from pre-clinical PET imaging systems to new PET molecular imaging probes to better understand human disease, has been told that a U.S. Patent (8,101,740) will be granted by the United States Patent Office on technology that has been exclusively licensed to Sofie. The patent covers a family of novel PET probes, known as [18F]FAC.

Positron Emission Tomography (PET) is a molecular imaging technology that utilizes minute amounts of labeled molecules ("probes") to target and measure biological and pharmacological processes. Basic scientists can use the same probes to examine cells and mice, as physicians do in patients to visualize and characterize the biology of disease, monitor its progression, and evaluate therapeutic efficacy.

Basic and clinical scientists at UCLA invented this novel PET probe, [18F]FAC, which was created by a slight modification of the drug molecule, gemcitabine, one of the most common drugs for cancer.  Cancer cells lack the normal checks and balances to limit cell growth.  [18F]FAC provides an in vivo imaging assay of cell growth known as the DNA salvage pathway.  Tumors use the salvage pathway to provide high rates of DNA replication for their uncontrolled growth of cells containing malignant instructions.

[18F]FAC measures the enzyme, dCK, which controls the rate of DNA production through the salvage pathway. Cancer drugs like gemcitabine use dCK to convert the drug into a pharmacologically active product that blocks the high rates of DNA replication for growth of malignant cells, and induces DNA damage in cancer cells. One of Sofie's objectives with [18F]FAC is to use PET imaging to allow physicians the means to search throughout the body for tumors that will respond to drugs that target dCK (like gemcitabine and other drugs), thus enabling more patient-specific treatment selecti
'/>"/>

SOURCE Sofie Biosciences
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Sofie Biosciences is Awarded a DOE Phase I SBIR to Commercialize Microscale Radiochemistry Platform
2. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2008
3. Carna Biosciences Signs Reagent Supply Agreement with Caliper Life Sciences
4. Pressure BioSciences, Inc. to Discuss Second Quarter 2008 Financial Results and Provide Business Update
5. Milestone Biosciences, LLC Further Strengthens Executive Management Team
6. Pressure BioSciences, Inc. Reports Second Quarter 2008 Financial Results and Provides Business Update
7. Access Pharmaceuticals Licenses MuGard to Milestone Biosciences, LLC for North America
8. Pressure BioSciences, Inc. Releases Novel, PCT-dependent Sample Preparation Kit for Systems Biology Studies
9. Neurocrine Biosciences to Present at Thomas Weisel Healthcare Conference and the NewsMakers in the Biotech Industry Conference
10. Start-Up and Emerging Biotech Companies Will Tell Their Stories at Biosciences Showcase Planned for MichBio Expo
11. Ardea Biosciences to Present Data on Lead MEK inhibitor, RDEA119, at EORTC-NCI-AACR Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... NJ (PRWEB) July 24, 2014 As ... manage numerous projects in the MENA region during 2014 ... have a preferred provider agreement with DZS to manage ... MENA region,” said Global VP of R&D and President ... has developed excellent operational practices with a focus on ...
(Date:7/23/2014)... YORK , July 24, 2014 ... Immune Pharmaceuticals Inc. (OTCQX and NASDAQ OMX First ... "Immune" or "the Company"), announced a collaboration to ... pemphigoid last night at an event attended by ... interested parties. Lyfebulb is a health and wellness ...
(Date:7/23/2014)... BioSciences, Inc. (NASDAQ: SGMO ) today reported ... For the second quarter ended June 30, ... million, or $0.10 per share, compared to a net ... the same period in 2013. As of June 30, ... and interest receivable of $236.7 million. Revenues ...
(Date:7/23/2014)... Physicists Sergei Filippov (MIPT and Russian Quantum Center ... Brno, Czech Republic, and the Institute of Physics ... preserve quantum entanglement of particles passing through an ... long distances. Details are provided in an article ... (see preprint). , Quantum entangled particles are ...
Breaking Biology Technology:SBI Pharmaceuticals Co. Ltd. Enters into Preferred Provider Agreement with DZS Clinical Services 2Innovative Collaboration To Increase Awareness Of Bullous Pemphigoid, A Rare Autoimmune Disease Of The Skin 2Innovative Collaboration To Increase Awareness Of Bullous Pemphigoid, A Rare Autoimmune Disease Of The Skin 3Innovative Collaboration To Increase Awareness Of Bullous Pemphigoid, A Rare Autoimmune Disease Of The Skin 4Innovative Collaboration To Increase Awareness Of Bullous Pemphigoid, A Rare Autoimmune Disease Of The Skin 5Sangamo BioSciences Reports Second Quarter 2014 Financial Results 2Sangamo BioSciences Reports Second Quarter 2014 Financial Results 3Sangamo BioSciences Reports Second Quarter 2014 Financial Results 4Sangamo BioSciences Reports Second Quarter 2014 Financial Results 5Sangamo BioSciences Reports Second Quarter 2014 Financial Results 6Sangamo BioSciences Reports Second Quarter 2014 Financial Results 7Sangamo BioSciences Reports Second Quarter 2014 Financial Results 8Sangamo BioSciences Reports Second Quarter 2014 Financial Results 9Scientists find way to maintain quantum entanglement in amplified signals 2Scientists find way to maintain quantum entanglement in amplified signals 3Scientists find way to maintain quantum entanglement in amplified signals 4
... announces that a new market research report is ... Health of Biotechnology and Drugs Industry in India ... The research services examines the financial ... 2 broad parameters- Excellence in financial management and ...
... Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN ) will ... Healthcare Conference on Monday, January 10, 2011.  The presentation ... Eastern Time).  The session may be accessed through the ... Relations page.  An archived version of the presentation will ...
... Using advanced technology to create high-quality dental lab ... mission of DentalLab.com ( http://www.dentallab.com ), a new full-service ... States and around the world. DentalLab.com was ... Holovchenko, an entrepreneur with a successful track record of ...
Cached Biology Technology:Reportlinker Adds Financial Health of Biotechnology and Drugs Industry in India and China 2Cutting-Edge Technologies Position DentalLab.com as Emerging Leader in Dental Lab Services Outsourcing 2
(Date:7/24/2014)... by the University of York has carried out the ... Indian Ocean. , The results, reported in the ... in the management of marine protected areas, with almost ... in the region now under local community stewardship. ... seas and coasts designed to protect wildlife from damage ...
(Date:7/24/2014)... his work with a new drug that successfully treated lupus ... has received a $250,000 grant to expand his research to ... treat a wider range of autoimmune diseases., Chandra Mohan, Hugh ... at UH, previously published a study in Arthritis Research & ... treated lupus in mice and reduced the number of cases ...
(Date:7/24/2014)... release is available in German . ... to recognize and respond to threats to health, and ... detailed understanding of the mechanism underlying immunologic memory, however, ... have converged to support the hypothesis that the persistence ... cells with stem-cell-like potential. Until now, there was no ...
Breaking Biology News(10 mins):Western Indian Ocean communities play vital role in conservation 2Biomedical engineer looks at new applications for novel lupus drug 2Biomedical engineer looks at new applications for novel lupus drug 3Experiments prove 'stemness' of individual immune memory cells 2Experiments prove 'stemness' of individual immune memory cells 3
... the biological sciences, mankind has struggled to comprehend the ... the arthropods. Now, a team of researchers, including Dr. ... History Museum of Los Angeles County (NHM), has finished ... the arthropods, answering many questions that defied previous attempts ...
... the Earth,s climate to slow or reverse global warming ... discussion. But before effective action can be taken, the ... Two Northwestern University studies, both published online recently by ... -- clues as to what drove large-scale changes to ...
... flies, has revealed a critical step in fly vision. Humans ... manifest as visual defects ranging from mild visual impairments to ... Biology paves the way for using the fruit fly ... Retinal dystrophies result from inherited defects in nearly every ...
Cached Biology News:Where did insects come from? 2Where did insects come from? 3The carbon cycle before humans 2The carbon cycle before humans 3All eyes on retinal degeneration 2
PTC-100 cycler with gold/silver block with Hot Bonnet heated lid, holds one 96-well V-plate or96x0.2ml tubes...
... Multimode Detectors provide unmatched value and ... and automation needs. Capable of performing ... the same instrument, the DTX Series ... can be integrated seamlessly with Beckman ...
... Deparaffinization Solution is available in a ... easy-to-use reagent for dewaxing paraffin-embedded tissue ... situ hybridization, or other analytical methods. ... consists of dipping the slides in ...
... The MJ Mini thermal cycler is a compact ... x 0.2 ml tubes, 12 x 0.5 ml ... heated lid uses a thumbwheel to adjust height ... oil-free cycling. Peltier heat pumps provide excellent thermal ...
Biology Products: